Adverum Biotechnologies Inc (ADVM)
2.91 -0.06 (-2.02%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 2.91 unch (unch) 04/25/25
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,927 | -122,116 | -154,536 | -145,540 | -117,507 |
| Depreciation Amortization | 1,746 | 3,709 | 5,648 | 10,134 | 4,679 |
| Accounts payable and accrued liabilities | -262 | -369 | 845 | -1,612 | 1,585 |
| Other Working Capital | 911 | -8,507 | 15,849 | 1,343 | 12,729 |
| Other Operating Activity | 36,070 | 36,381 | 24,103 | 27,844 | 19,223 |
| Operating Cash Flow | $-92,462 | $-90,902 | $-108,091 | $-107,831 | $-79,291 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -41,501 | 97,683 | 153,536 | 93,832 | -268,323 |
| PPE Investments | -388 | -808 | -11,816 | -15,123 | -11,844 |
| Investing Cash Flow | $-41,889 | $96,875 | $141,720 | $78,709 | $-280,167 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -240 | -61 |
| Common Stock Issued | 120,003 | 489 | 610 | 2,637 | 358,089 |
| Other Financing Activity | 0 | -420 | -3 | 0 | -2,043 |
| Financing Cash Flow | $120,003 | $69 | $607 | $2,397 | $355,985 |
| Beginning Cash Position | 76,976 | 70,934 | 36,698 | 63,423 | 66,896 |
| End Cash Position | 62,628 | 76,976 | 70,934 | 36,698 | 63,423 |
| Net Cash Flow | $-14,348 | $6,042 | $34,236 | $-26,725 | $-3,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | -92,462 | -90,902 | -108,091 | -107,831 | -79,291 |
| Capital Expenditure | -388 | -808 | -11,816 | -15,123 | -11,844 |
| Free Cash Flow | -92,850 | -91,710 | -119,907 | -122,954 | -91,135 |